S0950
StabilCoat® Immunoassay Stabilizer
Synonym(s):
Immunoassay Stabilizer, StabilCoat Reagent
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.84
UNSPSC Code:
12352202
Form:
liquid
Biological source:
bovine
General description
StabilCoat® immunoassay stabilizer effectively preserves the conformation and activity of dried proteins in immunoassays. It simultaneously blocks and stabilizes with superior results. StabilCoat immunoassay stabilizer stabilizes antibodies, antigens, or enzymes on various immunoassay platforms, such as polystyrene plates, tubes, glass, membranes, and filter paper.
Application
StabilCoat® Immunoassay stabilizer has been used to preserve:
- the immobilized antibody surface in a dried phase
- the surface plasmon resonance imaging (SPRi) gold chips containing antibodies and lectin
- in coating the antibody sensor chip to preserve it in the dry phase for antibody stabilization
Legal Information
StabilCoat is a registered trademark of SurModics, Inc.
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Instructions
Patjaree Peungthum et al.
The Analyst, 142(9), 1471-1481 (2017-03-28)
Low antigenic expression of ABO subgroup system on red blood cell (RBC) is cause of discrepancy between forward and reverse blood typing in the standard agglutination technique. Neutralization agglutination is employed for verification of the detection of ABH substances in
Krisda Sudprasert et al.
The Analyst, 140(3), 880-888 (2014-12-05)
A flow-induced cell movement assay combined with a surface plasmon resonance (SPR) technique was developed to quantify the agglutination strength, derived from the standard tube-agglutination test. Red blood cells (RBCs), based on the ABO blood group system, were specifically captured
Silvia Picciolini et al.
Journal of pharmaceutical and biomedical analysis, 192, 113649-113649 (2020-10-11)
One of the main hurdles in the study of Alzheimer's Disease (AD) is the lack of easily accessible and sensitive biomarkers for the diagnosis, the prediction of the disease progression rate and the evaluation of rehabilitative and pharmacological treatments. Extracellular
Global Trade Item Number
| SKU | GTIN |
|---|---|
| S0950-1L | 04061836831127 |